Dr. Reddys Laboratories Limited - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
RDY New York 2830 www.drreddys.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Dr. Reddys Laboratories Limited

RDY Q2 Earnings & Revenues Miss Estimates as Lenalidomide Sales Fall - Oct 26th, 2026 8:17 am
Dr. Reddy's Laboratories Q2 Earnings Call Highlights - Oct 23rd, 2026 12:04 pm
Top Stock Reports for Oracle, American Express & Progressive - Oct 12th, 2026 1:24 pm
NBIX vs. TEVA: Which Drugmaker Is the Better Investment? - Aug 25th, 2026 11:26 am
Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United States - Aug 3rd, 2026 11:39 pm
Dr Reddy's Laboratories Ltd (RDY) Q1 2027 Earnings Call Highlights: Navigating Challenges and ... - Jul 27th, 2026 7:01 pm
Dr. Reddy's Q1 Earnings and Revenues Miss Estimates, Stock Down - Jul 23rd, 2026 8:38 am
Dr. Reddy's Laboratories Q1 Earnings Call Highlights - Jul 22nd, 2026 11:06 am
Dr. Reddy's Laboratories Flags Semaglutide Supply Delay, Says No Recall Risk - Jul 12th, 2026 3:02 pm
Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F - Jun 26th, 2026 9:10 am
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading - Jun 18th, 2026 8:43 am
Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States - Jun 13th, 2026 4:22 am
Asian Equities Traded in the US as American Depositary Receipts Fall in Friday Trading - Jun 5th, 2026 8:38 am
NYSE Content Update: Dell Technologies Reports 88% Revenue Increase YoY - May 29th, 2026 6:55 am
Dr. Reddy's Laboratories Q4 Earnings Call Highlights - May 14th, 2026 6:09 am